Silvant Capital Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $72.7K | Hold |
853
| – | – | ﹤0.01% | 261 |
|
|
2025
Q4 | $67.4K | Hold |
853
| – | – | ﹤0.01% | 262 |
|
|
2025
Q3 | $68.2K | Hold |
853
| – | – | ﹤0.01% | 260 |
|
|
2025
Q2 | $77.5K | Sell |
853
-12,904
| -94% | -$1.18M | ﹤0.01% | 244 |
|
|
2025
Q1 | $1.29M | Buy |
13,757
+249
| +2% | +$22.3K | 0.06% | 141 |
|
|
2024
Q4 | $1.23M | Sell |
13,508
-97
| -0.7% | -$9.26K | 0.05% | 144 |
|
|
2024
Q3 | $1.41M | Sell |
13,605
-332
| -2% | -$33.8K | 0.06% | 135 |
|
|
2024
Q2 | $1.35M | Sell |
13,937
-188
| -1% | -$17.3K | 0.06% | 136 |
|
|
2024
Q1 | $1.27M | Buy |
14,125
+590
| +4% | +$50K | 0.06% | 140 |
|
|
2023
Q4 | $1.08M | Sell |
13,535
-1,867
| -12% | -$140K | 0.06% | 139 |
|
|
2023
Q3 | $1.1M | Sell |
15,402
-704
| -4% | -$52.6K | 0.07% | 144 |
|
|
2023
Q2 | $1.24M | Buy |
16,106
+899
| +6% | +$69.6K | 0.07% | 138 |
|
|
2023
Q1 | $1.14M | Sell |
15,207
-321
| -2% | -$23.9K | 0.07% | 128 |
|
|
2022
Q4 | $1.22M | Buy |
15,528
+314
| +2% | +$23.5K | 0.09% | 128 |
|
|
2022
Q3 | $1.07M | Sell |
15,214
-48
| -0.3% | -$3.76K | 0.07% | 128 |
|
|
2022
Q2 | $1.22M | Hold |
15,262
| – | – | 0.3% | 68 |
|
|
2022
Q1 | $1.16M | Sell |
15,262
-170
| -1% | -$13.5K | 0.22% | 82 |
|
|
2021
Q4 | $1.32M | Sell |
15,432
-651
| -4% | -$50.8K | 0.23% | 83 |
|
|
2021
Q3 | $1.22M | Sell |
16,083
-2,849
| -15% | -$226K | 0.22% | 85 |
|
|
2021
Q2 | $1.54M | Sell |
18,932
-311
| -2% | -$25.4K | 0.24% | 87 |
|
|
2021
Q1 | $1.52M | Sell |
19,243
-495
| -3% | -$38.8K | 0.26% | 84 |
|
|
2020
Q4 | $1.69M | Sell |
19,738
-8,230
| -29% | -$681K | 0.29% | 85 |
|
|
2020
Q3 | $2.16M | Sell |
27,968
-7,025
| -20% | -$536K | 0.4% | 68 |
|
|
2020
Q2 | $2.56M | Sell |
34,993
-2,174
| -6% | -$154K | 0.46% | 56 |
|
|
2020
Q1 | $2.47M | Sell |
37,167
-684
| -2% | -$48.2K | 0.54% | 50 |
|
|
2019
Q4 | $2.61M | Sell |
37,851
-382
| -1% | -$26K | 0.48% | 59 |
|
|
2019
Q3 | $2.81M | Sell |
38,233
-5,279
| -12% | -$383K | 0.56% | 53 |
|
|
2019
Q2 | $3.12M | Sell |
43,512
-4,033
| -8% | -$286K | 0.56% | 56 |
|
|
2019
Q1 | $3.26M | Sell |
47,545
-1,847
| -4% | -$119K | 0.59% | 51 |
|
|
2018
Q4 | $2.94M | Sell |
49,392
-1,306
| -3% | -$81.7K | 0.59% | 56 |
|
|
2018
Q3 | $3.39M | Sell |
50,698
-8,412
| -14% | -$560K | 0.42% | 81 |
|
|
2018
Q2 | $3.83M | Sell |
59,110
-666
| -1% | -$43.6K | 0.47% | 77 |
|
|
2018
Q1 | $4.28M | Buy |
+59,776
| New | +$4.3M | 0.55% | 71 |
|
Other funds holding CL
VCM
DAM
VPM
Silvant Capital Management's CL Position: Q1 2026 in Review
Silvant Capital Management held its Colgate-Palmolive (CL) position steady in Q1 2026 at 853 shares worth $72.7K. The position accounts for ﹤0.01% of the portfolio, ranked #261.
Silvant Capital Management first reported a position in CL in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.28M in Q1 2018. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Silvant Capital Management held 853 shares of Colgate-Palmolive worth $72.7K as of Q1 2026.
- Silvant Capital Management left its Colgate-Palmolive share count unchanged in Q1 2026.
- Colgate-Palmolive made up ﹤0.01% of Silvant Capital Management's portfolio in Q1 2026, its #261 holding.
- Silvant Capital Management first reported a position in Colgate-Palmolive in Q1 2018 and has held it in 33 quarters since.
- Silvant Capital Management's Colgate-Palmolive position peaked at $4.28M in Q1 2018.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.